CDKN2A and neoplasm: The occurrence of cellular senescence is primarily, as far as we know, dependent on the activation of major tumor-suppression pathways controlled by P53, RB1, and P16-INK4A proteins (Coppé et al., 2010), which have been recently considered to be biomarkers to detect and monitor cellular senescence in culture and ex-vivo specimens (Figure 3).